av/impel-pharmaceuticals--big.svg

COM:IMPELPHARMA

Impel Pharmaceuticals Inc.

  • Stock

USD

Last Close

0.06

20/12 20:58

Market Cap

956K

Beta: -

Volume Today

720.03K

Avg: -

  • name

    Impel Pharmaceuticals Inc.
  • homepage url

    impelpharma.com
  • country

    USUnited States
  • linkedin url

    impel-pharma
  • crunchbase url

    impel-pharmaceuticals
  • employee count

    160
  • sector

    Healthcare
  • industry

    Biotechnology
  • revenue

    12.65M
  • monthly webtraffic

    324
  • monthly webtraffic growth

    −20%
  • stage

    Debt
  • raised capital

    50M

Description

Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The company is also developing INP105,...Show More

peer of